JP2025512749A5 - - Google Patents
Info
- Publication number
- JP2025512749A5 JP2025512749A5 JP2024554877A JP2024554877A JP2025512749A5 JP 2025512749 A5 JP2025512749 A5 JP 2025512749A5 JP 2024554877 A JP2024554877 A JP 2024554877A JP 2024554877 A JP2024554877 A JP 2024554877A JP 2025512749 A5 JP2025512749 A5 JP 2025512749A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- amino acid
- acid residues
- amino acids
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22305312 | 2022-03-16 | ||
| EP22305312.5 | 2022-03-16 | ||
| PCT/EP2023/056642 WO2023175022A1 (en) | 2022-03-16 | 2023-03-15 | New method to treat infectious diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512749A JP2025512749A (ja) | 2025-04-22 |
| JP2025512749A5 true JP2025512749A5 (https=) | 2026-03-13 |
Family
ID=81324956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024554877A Pending JP2025512749A (ja) | 2022-03-16 | 2023-03-15 | 感染症の新しい治療法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250163116A1 (https=) |
| EP (1) | EP4493590A1 (https=) |
| JP (1) | JP2025512749A (https=) |
| KR (1) | KR20240159852A (https=) |
| CN (1) | CN119053620A (https=) |
| WO (1) | WO2023175022A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023219197A1 (en) * | 2022-02-14 | 2024-08-22 | Sumant Singh CHUGH | Methods of treating a cytokine storm related disease with recombinant mutated human angiopoietin-like 4 |
| WO2025247922A1 (en) * | 2024-05-28 | 2025-12-04 | Institut National de la Santé et de la Recherche Médicale | Use of the recombinant fibrinogen-like domain of angiopoietin-like 4 for treating sepsis capillary leak syndrome |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU643427B2 (en) | 1988-10-31 | 1993-11-18 | Immunex Corporation | Interleukin-4 receptors |
| WO1991018982A1 (en) | 1990-06-05 | 1991-12-12 | Immunex Corporation | Type ii interleukin-1 receptors |
| US6074849A (en) | 1995-07-19 | 2000-06-13 | Genetics Institute, Inc. | Polynucleotides encoding human CTLA-8 related proteins |
| US6569645B2 (en) | 1999-05-14 | 2003-05-27 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
| US6579520B2 (en) | 1998-05-15 | 2003-06-17 | Genentech, Inc. | IL-17 related mammalian cytokine polypeptides (IL-17E) |
| FR2827866B1 (fr) | 2001-07-27 | 2004-12-10 | Pasteur Institut | Peptides synthetiques ou naturels liant la proteine phosphatase 2a, methode d'identification et utilisations |
| WO2004011595A2 (fr) | 2002-07-26 | 2004-02-05 | Institut Pasteur | Vecteurs destines au transfert de molecules d'interet dans des cellules cibles |
| WO2011080132A2 (en) | 2009-12-17 | 2011-07-07 | Katholieke Universiteit Leuven, K.U. Leuven R&D | Compounds, compositions and methods for controlling biofilms |
| WO2016020880A2 (en) * | 2014-08-07 | 2016-02-11 | Novartis Ag | Angiopoietin-like 4 antibodies and methods of use |
| WO2016020882A2 (en) * | 2014-08-07 | 2016-02-11 | Novartis Ag | Angiopoetin-like 4 (angptl4) antibodies and methods of use |
| US11446398B2 (en) * | 2016-04-11 | 2022-09-20 | Obsidian Therapeutics, Inc. | Regulated biocircuit systems |
-
2023
- 2023-03-15 CN CN202380035128.9A patent/CN119053620A/zh active Pending
- 2023-03-15 JP JP2024554877A patent/JP2025512749A/ja active Pending
- 2023-03-15 WO PCT/EP2023/056642 patent/WO2023175022A1/en not_active Ceased
- 2023-03-15 EP EP23711079.6A patent/EP4493590A1/en active Pending
- 2023-03-15 US US18/842,489 patent/US20250163116A1/en active Pending
- 2023-03-15 KR KR1020247034395A patent/KR20240159852A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025512749A5 (https=) | ||
| FI4211231T3 (fi) | Peptidimodifioitu aav-kapsidi | |
| Tang | Specificity of pepsin and its dependence on a possible ‘hydrophobic binding site’ | |
| JP2023544683A5 (https=) | ||
| Narita et al. | The amino acid sequence of cardiotoxin from Formosan cobra (Naja naja atra) venom | |
| CN109641034A (zh) | 聚乙二醇化的猪干扰素及其使用方法 | |
| KR890003802A (ko) | 재조합 dna 기술에 의해 제조된 소의 췌장 트립신 억제제, 그 제조 방법, 발현 벡터 및 재조합 숙주 및 그의 제약적 용도 | |
| JP2001520238A5 (https=) | ||
| JP2021520818A5 (https=) | ||
| CN110563802B (zh) | 一组含n-甲基化氨基酸及n端脂肪酸修饰的抗菌肽类似物及其合成方法和应用 | |
| WO2022001075A1 (zh) | 眼镜蛇科蛇突触后神经毒素、心脏毒素、细胞毒素、磷脂酶a2及粗毒在抗病毒感染上的应用 | |
| CN116178506B (zh) | 一种订书肽及其用途 | |
| JP2854970B2 (ja) | マガイニンペプチドの置換アナログ | |
| CA1337407C (en) | Dimeric peptides having a stimulatory effect on haemopoiesis and a process for their preparation | |
| US10597426B2 (en) | Polypeptide compound and preparation method and use thereof | |
| US20180244724A1 (en) | Polypeptide compound and preparation method and use thereof | |
| JP2020127419A5 (https=) | ||
| CN108976298A (zh) | 一种来源于凡纳滨对虾血蓝蛋白的抗WSSV肽LvHcS52及其应用 | |
| JP2021531246A5 (https=) | ||
| JPH04505162A (ja) | 白血球エラスターゼとカテプシンｇとを阻害するペプチド、ｄｎａ、ベクター、宿主生物と取得の方法、並びにペプチドを含有する薬剤学的製剤 | |
| KR20180086277A (ko) | 폴리펩티드 화합물, 그리고 이의 제조 방법 및 적용 | |
| JP2023501308A5 (https=) | ||
| ATE350395T1 (de) | Diastereomere peptide und diese umfassende arzneimittel | |
| Corran et al. | The tryptic peptides of rabbit muscle triose phosphate isomerase | |
| JP2025511086A5 (https=) |